Mike Milburn, Ph.D.
Chief Scientific Officer
Dr. Milburn has
served as Chief Scientific Officer at Metabolon since 2005 and is responsible
for our metabolomics technology development, laboratory operations, informatics, and data science. Before
joining Metabolon, he was senior vice president of research and corporate
development at Sirtris Pharmaceuticals, where he led the preclinical/clinical
development of drugs in metabolic disease and neurodegeneration. Prior to
Sirtris, he held various senior-level positions at Plexxikon, Glaxo and
GlaxoWellcome. Dr. Milburn received his Ph.D. in biophysical chemistry from the
University of California, Berkeley and was a post-doctoral research fellow at
Harvard Medical School.